Clinical trial
Hepcidin Behavior in Patients With Obesity and Bariatric Surgery
NCT03990948 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepcidin Behavior in Patients With Obesity and Bariatric Surgery
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 8, 2019
- Completion date
- December 12, 2023
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepcidin